Why MACOM (MTSI) Stock Is Trading Up Today
MACOM Technology Solutions (MTSI) shares rose about 3% to $326.57 after Benchmark reinstated coverage with a Buy rating and a $375 price target, according to TipRanks. Benchmark said roughly two-thirds of revenue comes from higher-growth end markets. The article also cites Bloomberg reporting Anthropic’s Q2 revenue rose more than 14-fold to over $11.5B.
How this was made

The 30-second read
Why it matters
Benchmark’s reinstated Buy and $375 target are the immediate driver for the stock’s intraday move, while the broader AI funding narrative is used to justify the growth outlook.
Market read
Traders are reacting to a fresh analyst catalyst for MTSI, with additional sentiment support from AI-related revenue momentum and semiconductor cycle commentary.
What to watch
The article relies on read-through from other AI-related companies (Anthropic, server/cloud peers) rather than MACOM-specific order visibility or backlog changes.
Background
MACOM is a network chips supplier; the piece frames today’s move as a mix of analyst coverage and AI/semi cycle tailwinds.
Ticker impact
MACOM shares rose about 3% after Benchmark reinstated coverage with a Buy rating and a $375 price target.
Near-term upside bias while traders digest the upgrade and target; follow-through depends on whether AI/semi demand data continues to confirm the thesis.
The article’s only MACOM-specific new fact is Benchmark’s reinstated Buy and $375 target, alongside a general revenue-growth mix argument. It does not cite new MACOM financial results or guidance.
Market effects
Reinforces the market’s read-through that network-chip demand can benefit from AI capex and improving semiconductor cycle breadth.
Mentions early-August South Korea semiconductor export strength, supporting the broader AI/semi demand narrative.
Ties to global AI funding expectations, with Anthropic’s revenue jump used as a sentiment read-through for chip spend.
Counterpoint
Analyst reinstatement and a target can fade quickly if there is no new MACOM fundamental datapoint (earnings, guidance, orders).
Key entities
- companyMACOM Technology Solutions
Network chips maker whose shares jumped about 3% after Benchmark reinstated coverage with a Buy rating and $375 price target.
- analyst_firmBenchmark
Reinstated coverage of MACOM with a Buy rating and set a $375 price target, per the article.
- companyAnthropic
Reported preliminary Q2 revenue more than $11.5B, cited as evidence AI labs can keep funding chip spend.


